Mitsubishi UFJ Financial Group has become a substantial holder in Australian Clinical Labs, acquiring significant voting power through its interests in Morgan Stanley and First Sentier Investors. This strategic move highlights Mitsubishi's escalating influence in the company, with a total of 11,929,193 fully paid ordinary shares, representing a 5.92% voting power. Investors in the financial markets may find this development noteworthy as it reflects the shifting dynamics in corporate ownership and control.